About PharmaLex
PharmaLex is a company based in Mannheim (Germany) founded in 1998 was acquired by AmerisourceBergen in September 2022. The company has 267 employees. PharmaLex has completed 6 acquisitions, including Arbour Group, DRA and ERA Consulting. PharmaLex offers products and services including Strategic and Scientific Consultancy, Integrated Product Development, and Regulatory Affairs and CMC. PharmaLex operates in a competitive market with competitors including ProPharma Group, Validant, Technical Safety Services, Celegence and Pharma-Bio Serv, among others.
- Headquarter Mannheim, Germany
- Employees 267
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website pharmalex.com
- Social LinkedIn X Facebook YouTube
- Acquired by AmerisourceBergen (Sep 2022)
- Legal Name Pharmalex India Private Limited
- Date of Incorporation 23 May, 2013
- Jurisdiction Delhi, India
- Annual Revenue₹74.75 Cr
FY 2025 · -8% YoY
- Net Profit₹5.79 Cr
FY 2025 · 8% margin
- EBITDA₹9.31 Cr
FY 2025 · 12% margin
- Latest Funding Round$38.44K (USD), Grant
Jun 2022
- InvestorsAmerisourceBergen
& 2 more
- Employee Count267
- Investments & AcquisitionsArbour Group
& 5 more
- Acquired by
Associated legal entities of PharmaLex
PharmaLex operates through Pharmalex India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pharmalex India Private Limited CIN U85100DL2013FTC252553 | Active | 23 May 2013 | New Delhi, Delhi | ₹74.8 Cr | 267 | 2 | View details |
Products & Services of PharmaLex
PharmaLex offers a comprehensive portfolio of products and services, including Strategic and Scientific Consultancy, Integrated Product Development, and Regulatory Affairs and CMC.
Provides strategic advice for pharmaceutical and biotech development.
Offers end-to-end solutions for product innovation and market access.
Manages compliance and regulatory writing for industry standards.
Apps and channels of PharmaLex
its YouTube channel Cencora PharmaLex has 185 subscribers and 25 videos.
Videos from PharmaLex
The most watched videos on PharmaLex's YouTube channel, Cencora PharmaLex (185 subscribers). Click a video to play it here.
More on Cencora PharmaLex.
Funding Insights of PharmaLex
- Total Rounds 2
- Last Round Grant — $38,445
- First Round $775,182
(Jan 2019)
- Investors Count 1
All 2 funding rounds of PharmaLex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | $38,445 | Grant | – | – | |
| Jan 2019 | $775,182 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in PharmaLex
PharmaLex has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include AmerisourceBergen and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Pharmaceutical distribution and supply chain services are provided globally. | 1985 | amerisourcebergen.com | Chesterbrook, United States |
Investor details for PharmaLex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Pharmalex India Private Limited (PharmaLex)
Pharmalex India Private Limited is the primary company behind PharmaLex. The board of Pharmalex India Private Limited currently have 2 directors; the longest-serving is Pawan Kumar Suri, appointed in 2019. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pawan Kumar Suri DIN 08481004 | Managing Director | 01 Jul 2019 | 7 yrs 3 mo | Pharmalex India Private Limited |
| Christopher . Gauglitz DIN 10263076 | Director | 04 Sep 2023 | 3 yrs 1 mo | Pharmalex India Private Limited |
People of PharmaLex
14 people are tracked at PharmaLex (2 in leadership, 12 in team); the tracked headcount is 267.
| Name | Role | Group |
|---|---|---|
REGINA WILLIAMS | Director, Finance and Business Operations | Leadership |
Ron Bromley | CEO | Leadership |
Juhi Mittal | Senior Manager, Statistics | Team |
Krishna Vemulapalli | Senior Specialist, Statistics | Team |
Bess Dalby | Manager, Data Science | Team |
Yilu Jin | Sr.Specialist, Statistics | Team |
Matt Ryals | Manager, Data Science | Team |
Xin Ye | Statistical Analyst | Team |
Heather Robertson-Houck | Senior Specialist, Human Resources and Office Manager | Team |
Lira Pi | Senior Manager | Team |
Valentine Tagbo | Data Science Specialist | Team |
Pablo Villegas Mirón, Ph.D | Senior Data Scientist | Team |
Sonia Fernandez Arribas | Pharmacovigilance Manager | Team |
Jana Toon | Client Relationship Manager | Team |
Complete people profiles for PharmaLex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of PharmaLex
Figures of Pharmalex India Private Limited, the primary company behind PharmaLex, for FY 2025. Revenue was ₹74.75 Cr (-8% year on year). Net profit was ₹5.79 Cr (8% margin). EBITDA was ₹9.31 Cr (12% margin). Revenue has grown at a compounded annual rate of +10% over three years and +35% over five years.
- ₹74.75 CrRevenue · FY 2025 · -8% YoY
- ₹5.79 CrNet profit · 8% margin
- ₹9.31 CrEBITDA · 12% margin
- ₹20 LakhPaid-up capital
- 267Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +35%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Pharmalex India Private Limited are on its company page.
Detailed financial statements for PharmaLex
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PharmaLex
PharmaLex has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Arbour Group, DRA and ERA Consulting.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Market access services are provided to the biopharma sector. | dra.fi | Vantaa, Finland | 2002 | Aug 2022 | •••• | |
Regulatory affairs services for biologics are provided globally. | eraconsulting.com | London, United Kingdom | 1987 | Mar 2021 | •••• | |
Provider of regulatory compliance products and services for the life sciences industries | arbourgroup.com | Oak Brook, United States | 1990 | Feb 2020 | •••• | |
Provider of regulatory compliance services | deggegroup.com | Fairfax, United States | 1988 | Apr 2017 | •••• | |
Natural gas is transported via pipelines from production to markets. | safis-solutions.com | Indianapolis, United States | 2002 | Apr 2017 | •••• | |
Regulatory compliance services are provided to businesses since 1995. | jacobsenadvice.com | Sonderborg, Denmark | 1995 | Jul 2016 | •••• |
Complete acquisition details for PharmaLex
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of PharmaLex
10 dated milestones of PharmaLex across 24 years, from founding to its latest funding, stage changes and deals.
- Founded PharmaLex is founded.
- Acquisition Acquires Jacobsen Advice.
- Acquisition Acquires Safis Solutions.
- Acquisition Acquires The Degge Group.
- Funding First funding round of $775K.
- Acquisition Acquires Arbour Group.
- Acquisition Acquires ERA Consulting.
- Funding Latest funding round, Grant, of $38K.
- Acquisition Acquires DRA.
- Exit Acquired by AmerisourceBergen.
Competitors of PharmaLex
PharmaLex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ProPharma Group, Validant, Technical Safety Services, Celegence and Pharma-Bio Serv, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| propharmagroup.com | 2001 | Saint Paul, United States | – | 999 | Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device | |
| validant.com | 2005 | San Francisco, United States | $2.28M | – | Regulatory, compliance, and quality consulting for GxP lifecycles is provided. | |
| techsafety.com | 1970 | Berkeley, United States | – | 71 | Healthcare instrumentation, medical gas systems, and related devices are manufactured. | |
| celegence.com | 2017 | Downers Grove, United States | – | – | Regulatory consulting and solutions for pharmaceuticals and medical devices compliance. | |
| pharmabioserv.com | 1993 | Dorado, Puerto Rico | $11.75M | – | Provider of regulatory compliance and validation support to life science industries | |
| clinoutsolutions.com | 2013 | Tucson, United States | – | 38 | Regulatory support and consulting services are provided for clinical outcomes. | |
| mapigroup.com | 1990 | Lyon, France | $8.43M | – | Real world evidence and post-approval research services are provided. | |
| flyingbrands.co.uk | 1981 | Chelmsford, United Kingdom | – | – | Regulatory services are provided to the biopharma sector. | |
| trasis.com | 2004 | Ans, Belgium | – | 218 | Provides radiopharmaceutical equipment, synthesis solutions, and custom services for labs. |
Detailed competitors of PharmaLex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PharmaLex
The website of PharmaLex (pharmalex.com) receives about 19.2K visits a month and ranks #1,430,341 among all websites worldwide, #1,855 in Biotechnology and Pharmaceuticals.
- Monthly visits19.2K
▲ 2.9% vs previous month
- Unique visitors8.2K
per month
- Global rank#1,430,341
among all websites
- Category rank#1,855
Health · Biotechnology and Pharmaceuticals
- Bounce rate41%
- Pages per visit1.7
- Average visit12 sec
- DevicesDesktop 36% · Mobile 64%
Websites whose visitors overlap most with PharmaLex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
gmpsop.com | gmpsop.com | 100% | – | #1,167,332 | – |
pharmajobs.com | pharmajobs.com | 98% | – | #2,068,909 | – |
ifis.fr | ifis.fr | 98% | – | #2,902,096 | – |
eisai.de | eisai.de | 97% | – | #5,097,638 | – |
| merz.com | 95% | – | #848,298 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for PharmaLex
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Pharmalex
Complete news archive for PharmaLex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to PharmaLex
10 companies that operate in the same segment as PharmaLex (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PharmaLex
PharmaLex was founded in 1998 and raised its 1st funding round 21 years after it was founded.
PharmaLex is headquartered in Mannheim, Germany. It is registered at Mannheim, Baden-wurttemberg, Germany.
PharmaLex has 267 employees.
The primary company behind PharmaLex, Pharmalex India Private Limited, reported revenue of ₹74.75 Cr for FY 2025, down 8% year on year.
PharmaLex was founded in 1998 and operates as a contract research organization in the pharmaceutical sector from Mannheim, Germany. The current entity was established in 2015 through the merger of YES Pharma and PharmaLex. Services encompass development consulting, scientific affairs including clinical trial design and CTD documents, regulatory affairs such as procedure management and electronic submissions, and pharmacovigilance covering risk management, signal detection, and ICSR processing.
PharmaLex's top competitors include ProPharma Group, Pharma-Bio Serv and Validant.
PharmaLex offers Strategic and Scientific Consultancy, Integrated Product Development, and Regulatory Affairs and CMC.
PharmaLex has made 6 acquisitions, including Arbour Group, DRA, and ERA Consulting.
PharmaLex has 2 investors. Key investors include AmerisourceBergen, and European Union.
PharmaLex operates through Pharmalex India Private Limited.
Yes. PharmaLex was acquired by AmerisourceBergen in September 2022.
The legal entities of PharmaLex currently have 2 directors, including Christopher . Gauglitz, Pawan Kumar Suri.